
Cambrie's Story
Cambrie has epilepsy and has spent years trying nearly every available medication to control her seizures. When none worked, the care team at her children’s hospital recommended a neuromodulator—a surgical device commonly used when medications fail, even in young children.
Her surgery was scheduled for October 28. Just four days earlier, Cambrie’s family received devastating news: Anthem denied the procedure because Cambrie was not yet 18.
The denial came as a shock. In preparation for surgery, Cambrie had already undergone a head CT and a sedated MRI—tests Anthem had approved and paid for. Her neurologist and neurosurgeon both confirmed the surgery was medically appropriate and routinely performed on pediatric patients, including children much younger than Cambrie.
Still, Anthem said no.
Her doctors appealed the decision. Denied.
Her family filed an internal appeal. Denied.
They filed an external appeal. Denied again.
With no appeals left and no ability to change insurance through her father’s employer, Cambrie’s seizures continued while her family was left without options.
Out of desperation, Cambrie’s mother contacted NBC Nightly News. Months later, as NBC prepared to publish a story, Anthem requested a HIPAA release so it could comment on Cambrie’s case. Three days after the release was submitted, Anthem overturned the denial—despite no appeals being in progress.
As Cambrie’s mother put it, “Care didn’t get approved because it suddenly became necessary—it got approved because people started paying attention.”
Cambrie’s surgery is now scheduled, but the months‑long delay means critical imaging must be repeated before doctors can proceed. During the seven months Anthem denied care, Cambrie experienced two to four seizures every day. Those months of uncontrolled seizures carry potential long‑term effects on her development and health—effects her doctors say could have been avoided had care been approved when it was first recommended.
Cambrie’s story raises a troubling question: What happens to patients who don’t have the means or visibility to challenge an insurance company’s decision?












